Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2018-01-01
2018-08-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Oxytocin Dose Frequency on Behavioral and Neural Responses
NCT03610919
The Effects of Oxytocin on Affective Touch
NCT03282162
Oxytocin Effects on Likeability After Being Liked or Disliked
NCT02745431
The Role of Oxytocin in Modulating the Effects of Social Feedback on Achieving Personal Goals
NCT02740101
Oxytocin Modulates Eye Gaze Behavior During Social Processing
NCT03293511
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants are informed that they perform the reward learning task either for themselves, another (unknown) person or no one (control). In the probabilistc reward learning task, associations with two stimuli with different reward probabilities are learned via monetary feedback (reward ￥1 or no reward ￥0). After the experiment, participants need to finish the PANAS.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
male oxytocin group
male subjects with oxytocin treatment
Oxytocin
intranasal administration of oxytocin (24 IU)
male placebo group
male subjects with placebo treatment
Placebo
intranasal administration of placebo (24 IU)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxytocin
intranasal administration of oxytocin (24 IU)
Placebo
intranasal administration of placebo (24 IU)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* medical or psychiatric illness
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Electronic Science and Technology of China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Keith Kendrick
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Keith Kendrick, Dr.
Role: PRINCIPAL_INVESTIGATOR
University of Electronic Science and Technology of China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Life Science and Technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UESTC-neuSCAN-44
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.